儿童分化型甲状腺癌的初始与动态风险分层
该历史队列研究纳入77例接受甲状腺手术的儿童分化型甲状腺癌患者,按美国甲状腺协会(ATA)3组初始风险分层与4组动态风险分层(DRS)评估中位5.3年随访结局。结果显示仅ATA高风险组复发/持续病灶风险显著升高(HR 18.4,P=0.005);DRS中不确定反应组(HR 10.2,P=0.045)和结构不完全反应组(HR 98.7,P=0.005)风险显著高于极佳反应组。作者认为DRS可作为ATA儿童风险分层的补充用于预测复发/持续病灶。
要点
- ATA初始分层中仅高风险组复发/持续病灶风险显著升高(HR 18.4,P=0.005)。
- DRS不确定反应组(HR 10.2,P=0.045)与结构不完全反应组(HR 98.7,P=0.005)风险显著高于极佳反应组。
- 作者认为基于初始治疗反应的DRS可补充ATA儿童风险分层以预测复发/持续病灶。
核心结论
- 基于初始治疗反应的动态风险分层可补充ATA儿童风险分层,用于预测儿童分化型甲状腺癌的复发/持续病灶。
研究设计与样本
- 历史队列研究,纳入77例接受甲状腺手术的儿童分化型甲状腺癌患者,中位随访5.3年。
- 按3组ATA风险分层和4组动态风险分层(DRS)评估临床结局。
主要发现
- ATA风险分层中低危、中危、高危组分别占22%、48%、30%。
- 不确定风险组与低危组无病生存期无显著差异。
- 仅高危组复发/持续病灶风险显著升高(HR 18.4,P=0.005)。
- DRS中极佳反应、不确定反应、生化不完全反应、结构不完全反应组分别占49%、13%、6%、31%。
- 与极佳反应组相比,不确定反应组(HR 10.2,P=0.045)和结构不完全反应组(HR 98.7,P=0.005)复发/持续病灶风险显著升高。
临床怎么用
- 作者认为DRS基于初始治疗反应,可补充ATA儿童风险分层以预测复发/持续病灶。
局限性
- 原文未报告局限性
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: The objective of this study was to evaluate the usefulness of American Thyroid Association (ATA) risk classification and dynamic risk stratification (DRS) based on the response to initial therapy in pediatric patients with differentiated thyroid cancer (DTC). METHODS: This historical cohort study included 77 pediatric patients with DTC who underwent thyroid surgery. Clinical outcomes during median 5.3 years of follow up were assessed according to 3 ATA risk groups and 4 DRS groups. RESULTS: In ATA risk classification, 22%, 48%, and 30% of patients were in the low-, intermediate-, and high-risk groups, respectively. There was no significant difference in disease-free survival (DFS) between the indeterminate and the low-risk group. The risk of recurrent/persistent disease was significantly higher only in the high risk group [hazard ratio (HR), 18.4; P = 0.005]. In DRS, 49%, 13%, 6%, and 31% of patients were classified in the excellent, indeterminate, biochemical incomplete, and structural incomplete response groups, respectively. The risk of recurrent/persistent disease was significantly higher in the indeterminate group (HR, 10.2; P = 0.045) and in the structural incomplete group (HR, 98.7; P = 0.005) compared with the excellent response group. CONCLUSIONS: DRS based on the response to initial therapy could be useful in addition to initial ATA pediatric risk classification to predict recurrent/persistent disease in pediatric patients with DTC.
引用
- Sung TY, Jeon MJ, Lee YH, et al. Initial and Dynamic Risk Stratification of Pediatric Patients With Differentiated Thyroid Cancer. J Clin Endocrinol Metab. 2017. PMID: 27809646. doi:10.1210/jc.2016-2666
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。